A phase I/II study combining tosedostat with capecitabine in patients with metastatic pancreatic ductal adenocarcinoma (PDAC).

被引：0
|
作者：
Wang-Gillam, Andrea
Du, Lingling
Teague, Andrea S.
Suresh, Rama
Lim, Kian-Huat
Amin, Manik A.
Pedersen, Katrina
Tan, Benjamin R.
Huffman, Jess
Lockhart, Albert C.
机构：
[1] Washington Univ, Siteman Canc Ctr, St Louis, MO USA
[2] Barnes Jewish Hosp, St Louis, MO 63110 USA
[3] Washington Univ, Sch Med, St Louis, MO USA
[4] Washington Univ, Div Oncol, St Louis, MO USA
[5] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA
[6] Univ Kansas, Med Ctr, Kansas City, KS 66103 USA
[7] Mayo Sch Grad Med Educ, Rochester, MN USA
[8] Washington Univ, Sch Med, Div Oncol, St Louis, MO USA
[9] Washington Univ, St Louis, MO USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷 / 04期
关键词：
D O I：
10.1200/JCO.2017.35.4_suppl.410
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
410
引用
收藏
页数：1
相关论文
共 50 条
  • [1] A phase I/II study combining tosedostat with capecitabine in patients with metastatic pancreatic adenocarcinoma.
    Teague, Andrea S.
    Amin, Manik A.
    Lim, Kian-Huat
    Lockhart, Albert C.
    Masood, Ashiq
    Picus, Joel
    Singh, Preet Paul
    Suresh, Rama
    Tan, Benjamin R.
    Wang-Gillam, Andrea
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (04)
  • [2] Phase Ib/II study combining tosedostat with capecitabine in patients with advanced pancreatic adenocarcinoma
    Grierson, Patrick
    Teague, Andrea
    Suresh, Rama
    Lim, Kian-Huat
    Amin, Manik
    Pedersen, Katrina
    Tan, Benjamin
    Huffman, Jesse
    Boice, Nick
    Du, Lingling
    Liu, Jingxia
    Lockhart, A. Craig
    Wang-Gillam, Andrea
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2020, 11 (01) : 61 - 67
  • [3] A phase II study of abemaciclib as a monotherapy and in combination with other agents in patients with previously treated metastatic pancreatic ductal adenocarcinoma (PDAC).
    Chiorean, E. Gabriela
    Hochster, Howard S.
    Nanda, Shivani
    Thornton, Donald
    Klise, Suzanne
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [4] Characterization of primary and metastatic pancreatic tumors in pancreatic ductal adenocarcinoma (PDAC)
    Martinez-Muniz, Andres E.
    Sivanand, Sharanya
    Vander Heiden, Matthew
    CANCER RESEARCH, 2019, 79 (13)
  • [5] Phase I study of SEA-CD40, gemcitabine, nab-paclitaxel, and pembrolizumab in patients with metastatic pancreatic ductal adenocarcinoma (PDAC).
    Coveler, Andrew L.
    Bajor, David Lawrence
    Masood, Ashiq
    Yilmaz, Emrullah
    Shields, Anthony Frank
    Javle, Milind M.
    Paluri, Ravi Kumar
    Vaccaro, Gina M.
    Zalupski, Mark
    Grilley-Olson, Juneko E.
    Kindler, Hedy L.
    Schmitt, Michael W.
    Gutierrez, Martin
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [6] Comprehensive genomic analysis in metastatic pancreatic ductal adenocarcinoma (PDAC).
    Wong, Hui-Li
    Jones, Martin
    Eirew, Peter
    Karasinska, Joanna
    Schrader, Kasmintan A.
    Lim, Howard John
    Shen, Yaoqing
    Jones, Steven
    Yip, Stephen
    Laskin, Janessa J.
    Marra, Marco
    Schaeffer, David F.
    Renouf, Daniel John
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (04)
  • [7] A phase II study of peri-operative modified FOLFIRINOX in localized pancreatic ductal adenocarcinoma ( PDAC)
    Cecchini, Michael
    Salem, Ronald
    Robert, Marie
    Czerniak, Suzanne
    Rajaei, Moein
    Townsend, Jeffrey
    Blaha, Ondrej
    Zelterman, Daniel
    Thumar, Jaykumar
    Kortmansky, Jeremy
    Zaheer, Wajih
    Fischbach, Neal
    Persico, Justin
    Stein, Stacey
    Khan, Sajid
    Cha, Charles
    Billingsley, Kevin
    Kunstman, John
    Chowdhury, Sumedha
    Tseng, Robert
    Mauricio, Carlos
    Yugawa, Deanne
    Escobar-Hoyos, Luisa
    Johung, Kimberly
    Wiess, Christina
    Spickard, Erik
    Aushev, Vasily N.
    Laliotis, George
    Jurdi, Adham
    Liu, Minetta C.
    Lacy, Jill
    CANCER RESEARCH, 2024, 84 (02)
  • [8] Clinical impact of KRAS mutations in metastatic pancreatic ductal adenocarcinoma (PDAC)
    Norton, Carter
    Smith, Jarrod
    Rubnitz, Zach
    Tan, Grace H.
    Nevala-Plagemann, Christopher Duane
    Soares, Heloisa P.
    Garrido-Laguna, Ignacio
    Florou, Vaia
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) : 619 - 619
  • [9] Combining capecitabine and gemcitabine in patients with advanced pancreatic carcinoma: A phase I/II trial
    Hess, V
    Salzberg, M
    Borner, M
    Morant, R
    Roth, AD
    Ludwig, C
    Herrmann, R
    JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (01) : 66 - 68
  • [10] Phase II trial of capecitabine plus nab-paclitaxel in patients with metastatic pancreatic adenocarcinoma
    Scheithauer, Werner
    Kornek, Gabriela
    Prager, Gerald
    Stranzl, Nadja
    Laengle, Friedrich
    Schindl, Martin
    Friedl, Josef
    Klech, Julia
    Roethlin, Sabine
    Zielinski, Christoph
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2016, 7 (02) : 234 - 238
12345